Guggenheim Maintains Buy on Tempus AI, Raises Price Target to $92
10/1/2026
Impact: 80
Healthcare
Guggenheim analyst Subbu Nambi has maintained a Buy rating on Tempus AI (NASDAQ: TEM) and increased the price target from $65 to $92. This adjustment reflects a positive outlook on the company's performance.
AI summary, not financial advice
Share: